NUVB Insider Transactions
188 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.
NUVB insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Hattersley Gary | CHIEF SCIENTIFIC OFFICER | 2026-08-19 | Sale | 100,000 | $7.0924 |
| Sauvage Philippe | Chief Financial Officer | 2026-06-23 | Sale | 47,668.0 | $6.01 |
| Markel Stacy | CHIEF PEOPLE OFFICER | 2026-06-23 | Sale | 125,000.0 | $6.03 |
| Wentworth Kerry | CHIEF REGULATORY OFFICER | 2026-06-23 | Sale | 63,000.0 | $6.02 |
| Mashal Robert | Director | 2026-06-09 | Purchase | 25,000.0 | $4.73 |
| Liu Dongfang | CHIEF MEDICAL OFFICER | 2026-04-17 | Sale | 50,000.0 | $5.02 |
| Wentworth Kerry | CHIEF REGULATORY OFFICER | 2026-04-17 | Sale | 36,750.0 | $5.01 |
| Wentworth Kerry | CHIEF REGULATORY OFFICER | 2026-04-06 | Sale | 200,000.0 | $4.52 |
| Liu Dongfang | CHIEF MEDICAL OFFICER | 2025-12-01 | Sale | 150,000.0 | $7.82 |
| Liu Dongfang | CHIEF MEDICAL OFFICER | 2025-11-26 | Sale | 10,000.0 | $8.0 |
| Liu Dongfang | CHIEF MEDICAL OFFICER | 2025-11-25 | Sale | 10,000.0 | $7.5 |
| Liu Dongfang | CHIEF MEDICAL OFFICER | 2025-11-20 | Sale | 20,000.0 | $7.0 |
| Hattersley Gary | CHIEF SCIENTIFIC OFFICER | 2025-11-20 | Sale | 300,000.0 | $7.23 |
| Hattersley Gary | CHIEF SCIENTIFIC OFFICER | 2025-11-20 | Sale | 69,051.0 | $7.23 |
| Hanley David C. | CHIEF TECHNICAL OPERATIONS | 2025-11-19 | Sale | 200,000.0 | $7.14 |
| Liu Dongfang | CHIEF MEDICAL OFFICER | 2025-11-19 | Sale | 15,000.0 | $5.1 |
| Liu Dongfang | CHIEF MEDICAL OFFICER | 2025-11-17 | Sale | 15,000.0 | $4.77 |
| Hattersley Gary | CHIEF SCIENTIFIC OFFICER | 2025-10-27 | Sale | 100,000.0 | $5.02 |
| Markel Stacy | CHIEF PEOPLE OFFICER | 2025-06-18 | Purchase | 10,000.0 | $1.71 |
| Sauvage Philippe | Chief Financial Officer | 2025-06-17 | Purchase | 4,000.0 | $1.79 |
| Sauvage Philippe | Chief Financial Officer | 2025-06-16 | Purchase | 3,300.0 | $1.84 |
| Sjogren Colleen | Chief Commercial Officer | 2025-06-16 | Purchase | 50,000.0 | $1.81 |
| Wentworth Kerry | CHIEF REGULATORY OFFICER | 2025-06-16 | Purchase | 24,000.0 | $1.8 |
| Wentworth Kerry | CHIEF REGULATORY OFFICER | 2025-06-16 | Purchase | 26,000.0 | $1.79 |
| Hung David | PRESIDENT AND CEO | 2025-06-16 | Purchase | 500,000.0 | $1.79 |
| Liu Dongfang | CHIEF MEDICAL OFFICER | 2025-05-02 | Sale | 20,000.0 | $2.5 |
| Hung David | PRESIDENT AND CEO | 2025-04-07 | Purchase | 300,000.0 | $1.63 |
| Hung David | PRESIDENT AND CEO | 2025-04-04 | Purchase | 200,000.0 | $1.66 |
| Mashal Robert | Director | 2025-04-01 | Purchase | 98,900.0 | $1.67 |
| Mashal Robert | Director | 2025-04-01 | Purchase | 1,100.0 | $1.67 |
| Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | 2024-11-11 | Sale | 56,361.0 | $2.89 |
| Mashal Robert | Director | 2024-10-08 | Purchase | 99,981.0 | $2.2 |
| Mashal Robert | Director | 2024-10-08 | Purchase | 19.0 | $2.2 |
| Cui Xiangmin | Director | 2024-06-25 | Purchase | 277,895.0 | $2.97 |
| Cui Xiangmin | Director | 2024-06-24 | Purchase | 336,874.0 | $2.98 |
| Cui Xiangmin | Director | 2024-06-21 | Purchase | 75,411.0 | $3.0 |
| Cui Xiangmin | Director | 2024-06-20 | Purchase | 87,715.0 | $2.99 |
| BLICKENSTAFF KIM D | Director | 2024-06-11 | Purchase | 172,189.0 | $2.9 |
| NODELMAN OLEG | Director | 2023-09-21 | Purchase | 53,000.0 | $1.36 |
| EcoR1 Capital Fund, L.P. | Director | 2023-09-21 | Purchase | 53,000.0 | $1.36 |
| EcoR1 Capital, LLC | Director | 2023-09-21 | Purchase | 53,000.0 | $1.36 |
| EcoR1 Capital Fund Qualified, L.P. | Director | 2023-09-21 | Purchase | 53,000.0 | $1.36 |
| EcoR1 Venture Opportunity Fund, LP | Director | 2023-09-21 | Purchase | 53,000.0 | $1.36 |
| Biotech Opportunity GP, LLC | Director | 2023-09-21 | Purchase | 53,000.0 | $1.36 |
| NODELMAN OLEG | Director | 2023-09-20 | Purchase | 117,100.0 | $1.36 |
| EcoR1 Capital Fund, L.P. | Director | 2023-09-20 | Purchase | 117,100.0 | $1.36 |
| EcoR1 Capital, LLC | Director | 2023-09-20 | Purchase | 117,100.0 | $1.36 |
| EcoR1 Capital Fund Qualified, L.P. | Director | 2023-09-20 | Purchase | 117,100.0 | $1.36 |
| EcoR1 Venture Opportunity Fund, LP | Director | 2023-09-20 | Purchase | 117,100.0 | $1.36 |
| Biotech Opportunity GP, LLC | Director | 2023-09-20 | Purchase | 117,100.0 | $1.36 |
| NODELMAN OLEG | Director | 2023-09-19 | Purchase | 5,143,000.0 | $1.26 |
| EcoR1 Capital Fund, L.P. | Director | 2023-09-19 | Purchase | 5,143,000.0 | $1.26 |
| EcoR1 Capital, LLC | Director | 2023-09-19 | Purchase | 5,143,000.0 | $1.26 |
| EcoR1 Capital Fund Qualified, L.P. | Director | 2023-09-19 | Purchase | 5,143,000.0 | $1.26 |
| EcoR1 Venture Opportunity Fund, LP | Director | 2023-09-19 | Purchase | 5,143,000.0 | $1.26 |
| Biotech Opportunity GP, LLC | Director | 2023-09-19 | Purchase | 5,143,000.0 | $1.26 |
| NODELMAN OLEG | Director | 2023-02-21 | Purchase | 53,000.0 | $1.36 |
| EcoR1 Capital Fund, L.P. | Director | 2023-02-21 | Purchase | 53,000.0 | $1.36 |
| EcoR1 Capital, LLC | Director | 2023-02-21 | Purchase | 53,000.0 | $1.36 |
| EcoR1 Capital Fund Qualified, L.P. | Director | 2023-02-21 | Purchase | 53,000.0 | $1.36 |
| EcoR1 Venture Opportunity Fund, LP | Director | 2023-02-21 | Purchase | 53,000.0 | $1.36 |
| Biotech Opportunity GP, LLC | Director | 2023-02-21 | Purchase | 53,000.0 | $1.36 |
| NODELMAN OLEG | Director | 2023-02-20 | Purchase | 117,100.0 | $1.36 |
| EcoR1 Capital Fund, L.P. | Director | 2023-02-20 | Purchase | 117,100.0 | $1.36 |
| EcoR1 Capital, LLC | Director | 2023-02-20 | Purchase | 117,100.0 | $1.36 |
| EcoR1 Capital Fund Qualified, L.P. | Director | 2023-02-20 | Purchase | 117,100.0 | $1.36 |
| EcoR1 Venture Opportunity Fund, LP | Director | 2023-02-20 | Purchase | 117,100.0 | $1.36 |
| Biotech Opportunity GP, LLC | Director | 2023-02-20 | Purchase | 117,100.0 | $1.36 |
| NODELMAN OLEG | Director | 2023-02-19 | Purchase | 5,143,000.0 | $1.26 |
| EcoR1 Capital Fund, L.P. | Director | 2023-02-19 | Purchase | 5,143,000.0 | $1.26 |
| EcoR1 Capital, LLC | Director | 2023-02-19 | Purchase | 5,143,000.0 | $1.26 |
| EcoR1 Capital Fund Qualified, L.P. | Director | 2023-02-19 | Purchase | 5,143,000.0 | $1.26 |
| EcoR1 Venture Opportunity Fund, LP | Director | 2023-02-19 | Purchase | 5,143,000.0 | $1.26 |
| Biotech Opportunity GP, LLC | Director | 2023-02-19 | Purchase | 5,143,000.0 | $1.26 |
| FALBERG KATHRYN E | Director | 2022-12-05 | Purchase | 43,000.0 | $1.95 |
| FALBERG KATHRYN E | Director | 2022-12-02 | Purchase | 47,000.0 | $1.98 |
| FALBERG KATHRYN E | Director | 2022-12-01 | Purchase | 84,959.0 | $1.97 |
| FALBERG KATHRYN E | Director | 2022-11-30 | Purchase | 75,041.0 | $1.85 |
| Omega Fund V GP Manager, Ltd. | TenPercentOwner | 2022-04-05 | Sale | 2,500,000.0 | $5.6 |
| Omega Fund V, L.P. | TenPercentOwner | 2022-04-05 | Sale | 2,500,000.0 | $5.6 |
| Omega Fund V GP, L.P. | TenPercentOwner | 2022-04-05 | Sale | 2,500,000.0 | $5.6 |
| Omega Fund IV GP, L.P. | TenPercentOwner | 2021-12-15 | Sale | 500,000.0 | $10.07 |
| Omega Fund V GP Manager, Ltd. | TenPercentOwner | 2021-12-15 | Sale | 500,000.0 | $10.07 |
| Omega Fund V, L.P. | TenPercentOwner | 2021-12-15 | Sale | 500,000.0 | $10.07 |
| Omega Fund V GP Manager, Ltd. | TenPercentOwner | 2021-12-07 | Sale | 1,400,000.0 | $9.8 |
| Omega Fund V, L.P. | TenPercentOwner | 2021-12-07 | Sale | 1,400,000.0 | $9.8 |
| Omega Fund V GP, L.P. | TenPercentOwner | 2021-12-07 | Sale | 1,400,000.0 | $9.8 |
| NODELMAN OLEG | Director | 2021-11-24 | Purchase | 21,758.0 | $7.69 |
| EcoR1 Capital Fund, L.P. | Other | 2021-11-24 | Purchase | 21,758.0 | $7.69 |
| EcoR1 Capital, LLC | Other | 2021-11-24 | Purchase | 21,758.0 | $7.69 |
| EcoR1 Capital Fund Qualified, L.P. | Other | 2021-11-24 | Purchase | 21,758.0 | $7.69 |
| EcoR1 Venture Opportunity Fund, LP | Other | 2021-11-24 | Purchase | 21,758.0 | $7.69 |
| Biotech Opportunity GP, LLC | Other | 2021-11-24 | Purchase | 21,758.0 | $7.69 |
| NODELMAN OLEG | Director | 2021-11-24 | Purchase | 163,268.0 | $7.69 |
| EcoR1 Capital Fund, L.P. | Other | 2021-11-24 | Purchase | 163,268.0 | $7.69 |
| EcoR1 Capital, LLC | Other | 2021-11-24 | Purchase | 163,268.0 | $7.69 |
| EcoR1 Capital Fund Qualified, L.P. | Other | 2021-11-24 | Purchase | 163,268.0 | $7.69 |
| EcoR1 Venture Opportunity Fund, LP | Other | 2021-11-24 | Purchase | 163,268.0 | $7.69 |
| Biotech Opportunity GP, LLC | Other | 2021-11-24 | Purchase | 163,268.0 | $7.69 |
| Omega Fund V GP Manager, Ltd. | TenPercentOwner | 2021-11-23 | Sale | 36.0 | $9.75 |